High Frequency Chest Wall Oscillations (HFCWO ...

Jagtar Singh OBE - Chair Simon Gilby - Chief Executive

Coventry & Warwickshire Partnership NHS Trust Wayside House, Wilsons Lane, Coventry, CV6 6NY

Tel: 024 7636 2100 Fax: 024 7636 8949 www.covwarkpt.nhs.uk

HighFrequencyChestWallOscillations(HFCWO)&MechanicalInsufflation–Exsufflation(MI-E)Pathway

ThisdocumentrecommendscriteriatobeusedacrossCoventryandWarwickshirewhenrequestingfundingforhighfrequencychestwalloscillations(HFCWO)andmechanicalinsufflation-exsufflation(MI-E)forindividualpatientsalongsidetheavailableevidencebase.Thesedevicesareprovidedasstandardtreatmentinsomeareasforindividualswithneuromusculardisease(NMD)basedonrecommendedstandardsofcare(20,22,27,29).

HFCWOandMI-Earetypesofairwayclearancetechniquesusedbyrespiratoryphysiotherapiststoenhanceclearanceofexcessbronchialsecretions,totryandminimiseinfectionandthereforepreventrepeatedlungdamage.Thechild/youngperson(CYP)specificuseofthesetreatmenttechniquescanbetaughtbyarespiratoryphysiotherapist,tonurses,supportworkers,carersandfamiliesusingarespiratoryphysiotherapytreatmentplanaspartofacompetencytrainingpackage.

IfahealthcareprofessionalfeelstheHFCWO/MI-EmaybebeneficialfortheCYP,theymustdiscusswithmultidisciplinaryteam(MDT)includingtherespiratoryphysiotherapist.Arespiratoryassessmentmustbecarriedoutbyarespiratoryphysiotherapist.Ifacommunityrespiratoryphysiotherapistisnotavailable,fundingforaformalassessmentbyarespiratoryphysiotherapistmustbeagreedbyCCG.Devicecostsaredetailedinappendix1.

Device

CostofEquipment(excluding

1yearsupplyconsumables Rentalcosts Warranty TrialLoan

period

NippyClearwayBreasMedical(MI-Edevice)

£3300.00 £160.00

£190.00permonth,minimumrental12

1year 2months

E70CoughAssistPhilips

(MI-Edevice)

£3,436.51-£3,702.91

£33.28

£380.00permonth

1year 1month

TheVestHill-Rom

(HFCWOdevice)

£6,995.00 Noinitialcost

£10.00perday

minimumrental3month

2year 3months

1. InitialassessmentforHFCWO/MI-ETheCYPshouldbeassessedbyarespiratoryphysiotherapist(acuteorcommunity).ThechoiceofairwayclearancetechniqueisdecidedbytherespiratoryphysiotherapistandtheCYP/CYP’sfamily.Beforestarting,theremustbeclearindicationsandevidenceofotherairwayclearancetechniquesthathavebeentriedandhavenotbeeneffective.

CriteriaforHFCWO:TheHFCWOisusedtofacilitateairwayclearanceofsecretionsinCYPswhohaveacuteandchronicrespiratoryconditions.TheHFCWOrapidlyinflatesanddeflatesthevestcompressingandreleasingthechestwallcausinghighfrequencyoscillationswhichreplicatemini-coughs.Theseminicoughs,dislodgethemucusfromthewalloftheairwaysandwiththeincreasedstrengthoftheciliarybeatthroughresonance,helpstransportittothelargercentralairwaysforclearance.HFCWOmaybeconsidered:

• Acutechestinfectionwithsecretionretention• Chronicmucushypersecretionorsecretionretentionassociatedwithachronicpulmonary

orneuromuscularcondition• Alternativeairwayclearancetherapyprovenineffectiveorcontraindicatede.g.persistent

atelectasisdespitenormalairwayclearance• Longtermventilatedwithevidenceofsecretionretention• OngoingfatiguedespitetheinitiationofNIV,lackofstrengthorabilitytoperformactive

respiratoryphysiotherapytreatmente.g.activecycleofbreathing� Symptomatice.g.dailysecretionretention,recurrentrespiratoryinfections,SpO2<95%due

tosecretionretention,frequenthospitalisationse.g.threeormoreperannum,HDUandPICUadmissions,declineinlungfunction,regularantibiotics/steroidsrequiredforchestinfections

� Prolongedabsencefromschoolduetochestinfections.� Highburdenofcaree.g.siblingswithadditionalhealthcareneeds,otherdependants/

commitments,carerdisability,significantdependenceonchestphysiotherapyneed,relianceonotherstoassistwithmucusclearanceandphysicaldemandonpatientandcarerstoperformtreatment.

(1-17,36).

Appendix2haschartstoshowthecriteriaindicatedandtotalnumberofcriteriaforusingHFCWOinCYPinCoventryandWarwickshirePartnershipTrust(CWPT)andotherareasbetweenMarch2017andMay2018.InCWPT,thereare3CYPwhorequiredHFCWOandthetotalnumberofcriteriaindicatedwasbetween5and8.DatawasalsocollectedontheuseofHFCWOfromotherphysiotherapistsacrosstheUKworkingintheacutesectorandcommunity.Thetotalnumberofcriteriaindicatedfromotherareaswasbetween3and8.DuringthisdatacollectionitbecameevidentthatHFCWOisnotwidelyusedbytheothertrusts,andsoitwasdecidedtoonlyusethedatafromCWPTas3CYPareusingtheHFCWO.ItisthereforerecommendedthatifaCYPinCWPTmeets5ormoreofthecriteria,HFCWOmaybeconsidered.ThisisonlyaguideandclinicalreasoningshouldbeappliedwhenselectingappropriateairwayclearancedevicesfortheCYP.

CriteriaforMI-E:IneffectivecoughisamajorcauseofmortalityandmorbidityinCYPwithNMD.Thisleadstorecurrentpulmonaryinfectionwhichcausesprogressivelungdamageandpoorrespiratoryfunction;andeventuallyrespiratoryfailure.MI-EisusedasadevicetoaidCYPtoclearretainedbroncho-pulmonarysecretions.MI-EisalsousedwithCYPwhohavedecreasedinspiratoryeffort,duetoeitherspinalcordinjuryorNMD;andwhohaveanimpairedorineffectivecoughwithappropriaterespiratorysymptoms.MI-Eisconsideredwhenconventionalcoughassistancetechniques(e.g.breathstacking,manualassistedcough)becomeineffective.MI-Einflatesthelungswithgradualpositiveairwaypressurefollowedbyarapidswitchtonegativeairwaypressure.Thissimulatestheflowchangesthatoccurduringacough,andassistsclearanceofsecretions.MI-Emaybeconsidered:

• Acutechestinfectione.g.chestexacerbation,increaseinsputum• Chronicmucushypersecretionorsecretionretentionassociatedwithaneuromuscular

condition• Ineffectivecoughorinabilitytoremovemucusbycoughing.Indicationsforstartingcough

assistancetechniquesforCYPwithneuromuscularweakness:o InCYP,whoareabletoperformareproducibleforcedexpiratoryflowmanoeuvre,a

forcedvitalcapacity<50%ofpredictedisanindicationforMIE.o Inadultswithneuromuscularweakness,aPCF(peakcoughflow)>160litres/minis

necessaryforeffectivesecretionclearanceandaPCF>270litres/minisassociatedwithresiliencetorespiratoryinfection.TheminimumPCFacceptedasnormalis400litres/minandisreachedbetween12-13yrs.Thereforeindicated:

§ Inchildren>12yrswhohaveaPCF<270litres/min,particularlyiftheyhavehadepisodesofdeteriorationwithrespiratoryinfection.

§ Inchildren>12yrs,PCF<160litres/minisastrongpredictorofseverechestinfections,respiratoryfailureandindicatethatCYPshouldstartassistedcoughingmethods,evenintheabsenceofrespiratorycomplicationsinthemedicalhistory

• Wherebreathstackingand/ormanualassistedcoughprovenineffectiveorcontraindicatede.g.osteopenia,persistentatelectasisdespitenormalairwayclearance

• Longtermventilatedwithevidenceofsecretionretention• Clinicalevidenceofhyperinflationand/orairtrapping� OngoingfatiguedespitetheinitiationofNIV,lackofstrengthorabilitytoperformactive

respiratoryphysiotherapytreatment.� Symptomatice.g.dailysecretionretention,recurrentrespiratoryinfections,SpO2<95%due

tosecretionretention,frequenthospitalisationse.g.threeormoreperannum,HDUandPICUadmissions,declineinlungfunction,regularantibiotics/steroidsrequiredforchestinfections

� Prolongedabsencefromschoolduetochestinfections.

• Highburdenofcaree.g.siblingswithadditionalhealthcareneeds,otherdependants/commitments,carerdisability,significantdependenceonchestphysiotherapyneed,relianceonotherstoassist(18-36).

Appendix2haschartstoshowthecriteriaindicatedandtotalnumberofcriteriaforusingMIEinCYPinCWPTandotherareasbetweenMarch2017andMay2018.InCWPT,thereare4CYPwhorequiredMI-Eandthetotalnumberofcriteriaindicatedwasbetween6and9.Thetotalnumberofcriteriafromotherareasvariedbetween3to9.MI-Eisamorecommonlyuseddeviceanddatashowedacrosstheareasonaverage,theminimumnumberofcriteriaindicatedforusingMI-Ewas5ormore.ItisthereforerecommendedthatifaCYPinCWPTmeets5ormoreofthecriteria,MI-Emaybeconsidered.ThisisonlyaguideandclinicalreasoningshouldbeappliedwhenselectingappropriateairwayclearancedevicesfortheCYP.2. TrialPeriodTheHFCWO/MIEshouldonlybesetupandmodifiedbyatrainedrespiratoryphysiotherapist.TheRespiratoryPhysiotherapist’srolewillinclude:

• GainingagreementfromtheLeadconsultant–community/acute.ThereneedstobeanagreementthatthisleveloftreatmentisappropriateforlongtermusefortheCYPconsideringfactorssuchaspalliationbeforebeingdiscussedwithCYPandfamily.

• GainingconsentandcommunicationwithCYPandfamily• InformingCommunityChildren’sNurse(CCN)andcontinuingcaregroup/healthpanel.• Ifdevicestartedbyrespiratoryphysiotherapistintertiarycentre,needtoliaisewith

communityrespiratoryphysiotherapist.Ifcommunityrespiratoryphysiotherapistserviceunavailable,needtoconsiderhowtheCYPanddevicewillbemonitoredinthecommunity.

• Ifrecommendationispartofanewcontinuingcaresassessment,therespiratoryphysiowillprovidetheinformationtotheCCNtoincludeintheCYPassessment.

• InformotherhealthcareprofessionalsinvolvedinCYPcareasappropriate.• ArrangeloanequipmentfromHill-Rom,Philips,Nippybycompletingloanrequestformif

appropriate.• Providechildspecificrespiratoryphysiotherapytreatmentplantoincludebackup

treatmentifHFCWO/MI-Ebreaks.Tobewrittenbyrespiratoryphysiotherapist.• Arrangetrainingandcompletechildspecificcompetenciesforcarers/familymembersby

respiratoryphysiotherapist.• ConsiderwhereHFCWO/MI-Ewillbesetupandused:home/School/nursery/hospital/

hospice.• RespiratoryPhysiotherapisttodelivertrainingandcompletechildspecificcompetenciesfor

carers/familymembers• ProvideCYPfamilywithcontactnumbersforrespiratoryphysioandwhotocontactfor

consumablesifrequired.• Ifrentingdevice,additionalconsumableswillneedtobeaddedtorentalcosts.• Provideequipmentmanual&cleaninginstructionsplan.

Outcomemeasures:Duringtheassessmentatthebeginningofthetrialbytherespiratoryphysiotherapist,appropriateoutcomemeasureswillbedefinedtogetthebestobjectivefeedbackontheeffectivenessofthetreatmentduringthetrialperiod.Appropriatemembersofthefamilyorcareteamwillbeaskedtorecordtheseobjectivemeasurestoenabletherespiratoryphysiotherapisttoassesstheresultsofthetrial.Thefollowingisanexampleofsomeobjectivemeasuresthatmightbeused:

ShortTermmeasures• Observationofrespiratorypattern&rate• Auscultation• Oxygensaturations• Cough• Peakcoughflow• Sputum• Ventilatorsettings• Oxygenrequirement• Numberofsuctions/cathetersused

LongTermmeasures• Lungfunctiontest(astheygetolderandifable)• Chestx-rayifable• ComplianceandCYPperspective• Lengthoftreatment• Exercisetolerance• Microbiology• Numberofhospitaladmissions• Numberofrespiratoryinfections• Numberofcoursesofantibioticsforrespiratoryinfection• Easeofteaching/learning• Burdenofcare• Numberofcarersrequiredtoperformtreatment• Costs(directandindirecttobeevaluatedpriortostartingdevicee.g.lengthofhospitalstay

withassociatedward,HDUorPICUbedcosts,antibioticcoursesandcosts.

3. TrialSuccessfulTherespiratoryPhysiotherapisttoinform:

• CCNandcontinuingcaregroup/healthpanel.• Companyandrequestaformalquoteincludingconsumablesforayearandservicing/

warranty.• OncefundingagreedbyCCG,informhealthcareprofessionalsinvolvedasappropriate.

Oncepurchased,HFCWO/MI-EtohaveassetnumberandPATtestedasrequiredbytrustpolicy.Ongoingmonitoring,trainingoffamily/carers,CYPassessmentandcompetencyyearlyreviewbyacuteorcommunityrespiratoryphysiotherapist.Annualserviceandmaintenanceofequipmentaspermanufacturer’sguidance.Ensureprovisionofconsumables

AuthorAnnikaShepherd,ClinicalLeadRespiratoryPhysiotherapistCYPComplexPhysicalHealthServicesChildandFamilyServices,CWPTDate:October2018Specialthankstofollowingprofessionalsforcommentsandinformation:EmilyParry,CommunityChildren’sNurse,SouthWarwickshireNHSFoundationTrustDonnaPowell,LeadnurseforChildren’sContinuingCare,SouthWarwickshireNHSFoundationTrustLouiseBridges,ServiceManager,CYPComplexPhysicalHealthServicesChildandFamilyServices,CWPTAssociationofPaediatricChartedPhysiotherapist(APCP)respiratorycommittee:LaurenWilliams,AdvancedPhysiotherapist,SheffieldChildren’sHospitalSheonaStubbs,TeamLeadPaediatricPhysiotherapist,SerennuChildren'sCentre,NewportJoThornton,SpecialistPaediatricPhysiotherapist,BurnleyHospitalRachelEvans,IndependentPaediatricRespiratoryPhysiotherapistZoeJohnstone,ClinicalSpecialistRespiratoryPhysiotherapist,RHSCEdinburghAlliedHealthprofessionalsMidlandsLongTermVentilationNetwork:NickyMcNarry,RegionalLTVClinicalSpecialistPhysiotherapist,NottinghamChildren’sHospitalNicRutter,ContinuingCareTeamSpecialistPhysiotherapist,DerbyChildren’sHospitalDrMichelleChatwin,ConsultantPhysiotherapist,RoyalBromptonHospital.

HFCWOReferences

1. AnbarRD(1998)CompliancewithuseofThAIRapyVestbypatientswithcysticfibrosis,PaediatricPulmonol1998(suppl17):346,A497

2. AnbarRD.(1999)UseofThAIRapy®Vestdoesnotaffectliverfunctionofpatientswithcysticfibrosis.AmJRespirCritCareMed;159(3),A687.

3. Appetal(1998)PhysiotherapyandmechanicalbreakdownoftheexcessiveDNAloadinCFsputum-ananti-inflammatorytherapeuticstrategy,PaediatricPulmonology,suppl17;349,A507.

4. ButlerS,O’NeillB(1995)Highfrequencychestcompressiontherapy:acasestudy.PediatrPulmonol;19:56-59.

5. Burnettetal(1993)Comparativeefficacyofmanualchestphysiotherapyandahighfrequencychestcompressionvestininpatienttreatmentofcysticfibrosis,AmRevRespirDis1993;(suppl147):A30

6. CastagninoM,VojtovaJ,KaminskiS,FinkR(1996)SafetyofHighFrequencyChestWallOscillationinpatientswithrespiratorymuscleweakness.Chest;110:S65.

7. ChiappettaA,BeckermanR(1995).HighFrequencyChestWallOscillationinspinalmuscularatrophy(SMA).RTJRespirCarePract;8(4):112-114.

8. GomezA,ElisanI,HardyK(2000)HighFrequencyChestWallOscillation:videodocumentationofeffectonapatientwithduchenne’smusculardystrophyandseverescoliosis.Posterpresentationatthe46thInternationalRespiratoryCongressoftheAmericanAssociationforRespiratoryCare,October7,Cincinnati,Ohio,USA.

9. Hansenetal(1990)Highfrequencychestcompressionsystemtoaidinclearanceofmucusfromthelung.BiomedInstrumTechnolo,24,pp289-294

10. Kluftetal(1996)AcomparisonofbronchialdrainagetreatmentsinCF,PaediatricPulmonol,Oct1996,22(4),p271-4

11. Ndukwuetal(1999)ComparisonofHFCWOandmanualchesttherapyinlongtermacutecarehospitalventilator-dependantpatients,Chest,116

12. OermannCMetal(2001)ComparisonofHFCWOandoscillatingPEPinhomemanagementofCF:apilotstudy,PaediatricPulmonolv32,no.5,Nov,p372-377

13. PiquetJ,BrochardL,IsabeyD,DeCremouxH,ChangHK,BignonJ,HarfA.(1987)Highfrequencychestwalloscillationinpatientswithchronicairwayobstruction,AmRevRespiratorydisease,136,pp1355-1359

14. PerryRJ,ManGCW,JonesRL(1998)Effectsofpositiveend-expiratorypressureonoscillatedflowrateduringhighfrequencychestcompression.Chest;113(4):1028-1033.

15. Robinsonetal(1992)Evaluationofahighfrequencychestcompressiondeviceincysticfibrosis,PaediatricPulmonol1992;(suppl8):304,A225

16. Whitmanetal(1993)Preliminaryevaluationofhighfrequencychestcompressionforsecretionclearanceinmechanicallyventilatedpatients.RespiratoryCare,38(10),pp1081-108

17. NICE:TheVestfordeliveringhigh-frequencychestwalloscillationinpeoplewithcomplexneurologicalneeds:Medtechinnovationbriefing(2018)

MI-EReferences

18. Andersonetal.Systematicreviewoftechniquestoenhancepeakcoughflowandmaintainvitalcapacityinneuromusculardisease:thecaseformechanicalinsufflation-exsufflation.PhysicalTherapyReview2005;10:25-35

19. BachJR.Amyotrophiclateralsclerosis:prolongationoflifebynoninvasiverespiratoryAIDS.Chest.2002;122(1)92-8

20. Birnkrant(2018)DiagnosisandmanagementofDuchennemusculardystrophy,part2:respiratory,cardiac,bonehealth,andorthopaedicmanagement.LancetNeurology,vol17

21. BritishThoracicSocietyGuidelineforrespiratorymanagementofchildrenwithneuromuscularweakness;JeremyHull,RoonaAniapravan,ElaineChan,MichelleChatwin,JulianForton,JayneGallagher,NeilGibson,JillGordon,ImeldaHughes,ReneeMcCulloch,RobertRossRussell,AnitaSimonds,Thorax;July2012,vol27

22. BritishThoracicSociety/ACPRCguidelines;Physiotherapymanagementoftheadult,medicalspontaneouslybreathingpatientMay2009

23. ConsensusStatementonStandardofCareforCongenitalMuscularDystrophies(2010)JournalofChildNeurology25(12)1559-1581

24. CWPT:Community–ChildrenandYoungPeople:ClearwayMechanicalInsufflation-ExsufflationClinicalProcedure

25. Fauroux B, GuillemotN, AubertonG,NathanN, Labit A, Clement A, et al. Physiologic benefits ofmechanical insufflation-exsufflation in childrenwithneuromusculardiseases.Chest.2008;133(1):161-8.

26. Finkeletal(2018)Diagnosisandmanagementofspinalmuscularatrophy:Part2:Pulmonaryandacutecare;medications,supplementsandimmunizations;otherorgansystems;andethics.NeuromuscularDisorders28,197–207

27. GuerinC:BourdinG:LerayV;DelannoyB;BayleF;GermainM;RichardJC(2011)performanceofthecoughassistinsufflations-exsufflationdeviceinthepreseanceofanendotrachealtubeoftrachesotomytube:abenchstudy.RespiratoryCare;August;vol56,vol56,no.8.

28. Kravitz,R.(2009).AirwayclearanceinDuchenneMuscularDystrophy.Pediatrics,123(Suppl4)29. NHSEngland'sservicespecificationforneurosciences:specialisedneurology(adult)D04/S/a-Annex

Bincludeschildren201330. RespiratoryCareofthePatientwithDuchenneMuscularDystrophy:ATSconsensusStatement.AmJ

RespirCritCareMed.2004August15,2004:170(4)456-6531. ToussaintM(2011).Theusemechanicalinsufflations-exsufflationviaartificialairways.Respiratory

Care;August;vol56,No6.pp1217-9.32. Wang,Cetal(2007)ConsensusStatementforStandardofCareinSpinalMuscularAtrophy,Journal

ofChildNeurology,Volume22Number8,August20071027-104933. Winck,JC,Goncalves,MR,Lourenco,C,etalEffectsofmechanicalinsufflation-exsufflationon

respiratoryparametersforpatientswithchronicairwaysecretionencumbrance.Chest2004;126,774-780

34. Winck,JC,Goncalves,MR.Commentary:Exploringthepotentialofmechanicalinsufflation–exsufflationBreathe,June2008,Vol4,No4

35. Winfield,N.(2014).Non-pharmaceuticalmanagementofrespiratorymorbidityinchildrenwithsevereglobaldevelopmentaldelay.TheCochraneDatabaseofSystematicReviews

36. Chatwin,Metal(2018)Airwayclearancetechniquesinneuromusculardisorders:Astateoftheartreview,RespiratoryMedicine136,98-100

Appendix(1)

Quotes(March2018)NippyClearwayBreasMedical(MI-Edevice):(excludingVAT)

• Costofequipment:£3300.00withstarterpack.• 1Yearsupplyofconsumables:Mask,Tubeandfilterboxof12for1year£160.00.Replace

monthly.Thismayvarydependingonlocalinfectioncontrolpolicy.• Rentalcosts:£190.00permonthincludesdeviceandconsumables.Minimum12weeks

rental.Nodailyrentaloption• Warranty:1year• Servicingoptions:Differentoptions.Bronzeservice(annualServicewithnoloandevice)

£150.00,Silver£500.00andGold£780.00.Maybeabletobeservicedlocally.• TrialLoanperiod:2monthsnocharge

E70CoughAssistPhilips(MI-Edevice):(excludingVAT)

• Costofequipment:£3,436.51or£3,702.91withbattery,circuitsx12andfilters• 1Yearsupplyofconsumables:circuit,interfaceandfilterperpack£16.64sox2£33.28per

year.Replace6monthly.Thismayvarydependingonlocalinfectioncontrolpolicy.• Rentalcosts:£380.00permonth• Warranty:1year• Servicingoptions:Differentoptions.Bronzeservice£255.00,Silver£340.00andGold

£298.00for1styear.Maybeabletobeservicedlocally.• TrialLoanperiod:1monthnocharge

TheVestHill-Rom(HFCWOdevice):(excludingVAT)

• Costofequipment:£6,995forunit(airpulsegenerator),hoses,twopermanentgarments,remote,manualandbluebag.

• 1Yearsupplyofconsumables:Permanentgarments(£275-295.00each)andhoses(£25.00set)shouldlast2-3years.

• Rentalcosts:£10.00perdaywithminimumrental3monthperiod• Warranty:2years• Servicingoptions:Fixedpricerepair£399.00.Differentoptionsfrom£245.00to£358.00

excludingVAT.Maybeabletobeservicedlocally.• TrialLoanperiod:3monthnocharge

FundingacrossUKTherearelargevariationsinhowequipmentisfundedacrossservicesinEngland,ScotlandandWales.ThismaydependonlocalCCGagreements.

• InScotlandandWales,donotapplyforfundingforequipmentsuchasventilatorsandcoughassist.Maybeprovidedbytertiarycentre.

• UHNMhaveaCCGfundingagreementforcoughassists

Appendix2

AcharttoshowthecriteriaindicatedforusingHFCWOinCYPinCWPTandotherareasbetween

March2017andMay2018.

Atotalof6CYPwereusedinthissurvey.ThechartshowsthecriteriaindicatedforusingHFCWOineveryCYPwere:

• Chronicmucushypersecretionorsecretionretentionassociatedwithachronicpulmonaryorneuromuscularcondition

• OngoingfatiguedespitetheinitiationofNIV,lackofstrengthorabilitytoperformactiverespiratoryphysiotherapytreatment

• Highburdenofcare

Acutechestinfectio

secretion

retention

Chronicmucushypersecretionorse

cretion

retentionassociated

achron

onaryorneu

romuscularcon

Alternativeairw

ayclearanceth

proven

ineffectiveorcon

traind

icated

Longte

tilated

secretionretention

Ongoingfatig

uedespiteth

einitiationof

NIV,lackofstrengthora

bilitytoperform

erespira

toryphysio

therapytreatm

Symptom

Prolon

gedabsencefrom

chestinfectio

Highburde

nofcare

NoofCYP

AcharttoshowthetotalnumberofcriteriaindicatedforusingHFCWOinCYPinCWPTandotherareasbetweenMarch2017andMay2018.

EachcolumnrepresentsoneCYPinanarea.InCWPT,thereare3CYPwhorequiredHFCWOandthetotalnumberofcriteriaindicatedwasbetween5and8.ThedatawascollectedfromotherphysiotherapistsacrosstheUKworkinginacuteandcommunitysectors.Thetotalnumberofcriteriaindicatedfromotherareaswasbetween3and8.HFCWOisnotwidelyusedandsoitwasdecidedtousethedatafromCWPTas3CYPareusingtheHFCWO.IfaCYPinCWPTmeets5ormoreofthecriteria,HFCWOmaybeconsidered.ThisisonlyaguideandclinicalreasoningshouldbeappliedwhenselectingappropriateairwayclearancedevicesfortheCYP.

NUH CWPT CWPT CWPT RHSC Sheffield

Noofcriteria

AcharttoshowthecriteriaindicatedforusingMIEinCYPinCWPTandotherareasbetweenMarch2017andMay2018.

Atotalof65CYPwereusedinthissurvey.ThechartshowsthecriteriaindicatedineveryCYPforusingtheMIEwas:

• IneffectivecoughorinabilitytoremovemucusbycoughingThenextmostcommoncriteriaindicatedforusingtheMIEwere:

• OngoingfatiguedespitetheinitiationofNIV,lackofstrengthorabilitytoperformactiverespiratoryphysiotherapytreatment

• Wherebreathstackingand/ormanualassistedcoughprovenineffectiveorcontraindicated• Highburdenofcare

Acutechestinfectio

secretion

retention

Chronicmucushypersecretionor

secretionretentionassociated

chronicpu

aryorneu

romuscular

Ineffectivecoughorinabilityto

remove

mucusbycoughing

rebreathstackingand

assistedcoughproven

ineffectiveor

contraindicated

Longte

tilated

secretionretention

Clinicalevide

nceofhyperinfla

tionand/

orairtrapping

Ongoingfatig

uedespiteth

einitiationof

NIV,lackofstrengthora

bilityto

performactiverespira

physiotherapytreatm

Symptom

Prolon

gedabsencefrom

chestinfectio

Highburde

nofcare

NoofCYP

AcharttoshowthetotalnumberofcriteriaindicatedforMIEinCYPinCWPTandotherareas

betweenMarch2017andMay2018.

InCWPT,thereare4CYPwhorequiredMI-Eandthetotalnumberofcriteriaindicatedwasbetween6and9.Thetotalnumberofcriteriafromotherareasvariedbetween3to9.MI-Eisamorecommonlyuseddeviceanddatashowedacrosstheareasonaverage,theminimumnumberofcriteriaindicatedforusingMI-Ewas5ormore.IfaCYPinCWPTmeets5ormoreofthecriteria,MI-Emaybeconsidered.ThisisonlyaguideandclinicalreasoningshouldbeappliedwhenselectingappropriateairwayclearancedevicesfortheCYP.NB:Sheffieldcriteria:TheonepatientwithsignificantlylowercriteriahadAtaxia-telangiectasia(AT)andadvisedtoprovideMI-EfromspecialistcentreduetoareducedPCFresult(asidentifiedinstandardsandseecriteriaabove).

Private

Sheffie

Noofcriteria

High Frequency Chest Wall Oscillations (HFCWO ...

Documents

Transcript of High Frequency Chest Wall Oscillations (HFCWO ...

Neutrino Oscillations - Harvard University Department …users.physics.harvard.edu/~feldman/Neutrino_Oscillations.pdf · Gary Feldman Neutrino Oscillations Oscillations In analogy

Chest Trauma Chest Drain & Needle Decompression Trainerassets.limbsandthings.com/documents/2014_20-22_Chest_Trauma.pdf · 20 Chest Trauma Chest Trauma Chest Drain & Needle Decompression

Wigner oscillations and fractional Wigner oscillations in ...exotic.phy.bme.hu/SeminarPresentations/Traveso_2015.pdfFractional Wigner oscillations. WIGNER CRYSTAL Electron liquid Usually

Oscillations Q

Oscillation Analysis...referred to as local, intra-plant, inter-area, and torsional oscillations. System Oscillations and Forced Oscillations • Forced Oscillations: sustained oscillations

12 - Oscillations - City Tech OpenLab · 4/12/2019 · Oscillations Oscillations are when something repeats with the same period. Oscillations may seem like something that doesn't

Title of Presentation - KUET · (ii) Undamped Oscillations (i) Damped Oscillations: The electrical oscillations whose amplitude goes on decreasing with time are called damped oscillations.

Chest PA Chest Lat

Neutrino oscillations Oleg Lychkovskiy ITEP2008. Plan Lecture I Lecture I Introduction Introduction Two-flavor oscillations Two-flavor oscillations Three-

Electromagnetic Oscillations and Alternating Current LC Oscillations Damped Oscillations in RLC Circuits Alternating Current Resistive, Capacitive, Inductive.

To examine the physiologic effects of HFCWO and PEP breathing on: Ventilation Distribution

Oscillations Worksheet

Damped Forced Oscillations Coupled Oscillations 1.

Subsynchronous Oscillations

Waves & Oscillations

Oscillations - LiU

Damped oscillations

Dwarf Nova Oscillations and Quasi-Periodic Oscillations in ...

Power Oscillations

Simple pendulum Physical pendulum Diatomic molecule Damped oscillations Driven oscillations Lecture 24: General Oscillations.